Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Vinco Ventures Postpones Shareholder Call

Vinco Ventures advises that it has postponed the shareholder call scheduled for August 23rd, 2022. On August 19, 2022, the Eighth Judicial District Court for the State of Nevada appointed an interim, neutral, and
byBenzinga Newsdesk
August 23, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Vinco Ventures advises that it has postponed the shareholder call scheduled for August 23rd, 2022. On August 19, 2022, the Eighth Judicial District Court for the State of Nevada appointed an interim, neutral, and independent party, former Secretary of State of Nevada, Ross Miller, Esq, to serve as co-CEO alongside co-CEO’s John Colucci and Lisa King. This action by the court indicates a strong affirmation of the benefits of maintaining corporate stability and signals Nevada’s interest in protecting Vinco Venture’s shareholders and ongoing business operations. The call will be rescheduled for a later date

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Ionis and Astrazeneca’s Eplontersen Demonstrated a Statistically Significant and Clinically Meaningful Change From Baseline for Co-primary and Secondary Endpoints at 35 Weeks vs External Placebo Group

By Charles Gross
September 7, 4:50 AM
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today presented positive results from a planned 35-week interim analysis of the Phase 3 NEURO-TTRansform study of Ionis and AstraZeneca's eplontersen in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN).

AZN